FDA ODE IV Director Feigal to join CBER as deputy director for medicine.
Executive Summary
FDA OFFICE OF DRUG EVALUATION IV DIRECTOR RECRUITMENT UNDER WAY to find a replacement for David Feigal, MD, who will be joining the Center for Biologics Evaluation & Research as deputy director for medicine effective Sept. 1. FDA will also have to step up its efforts to recruit a permanent director of the Division of Antiviral Drug Products: acting director Donna Freeman will be leaving the agency at the end of August.